Emergent Biosolutions
EBS
EBS
141 hedge funds and large institutions have $208M invested in Emergent Biosolutions in 2024 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 35 increasing their positions, 36 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
141
Holders Change
+19
Holders Change %
+15.57%
% of All Funds
2.05%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.01%
New
49
Increased
35
Reduced
36
Closed
29
Calls
$3.09M
Puts
$5.83M
Net Calls
-$2.74M
Net Calls Change
-$3.33M
Top Buyers
| 1 |
1
American Century Companies
Kansas City,
Missouri
|
$6.01M |
| 2 |
CCM
2
Carronade Capital Management
Darien,
Connecticut
|
$3.76M |
| 3 |
3
D.E. Shaw & Co
New York
|
$5.65M |
| 4 |
4
JPMorgan Chase & Co
New York
|
$4.43M |
| 5 |
5
Jane Street
New York
|
$3.35M |
Top Sellers
| 1 |
1
BlackRock
New York
|
$26.2M |
| 2 |
2
Charles Schwab
San Francisco,
California
|
$21.6M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$1.35M |
| 4 |
4
Renaissance Technologies
New York
|
$1.18M |
| 5 |
APM
5
Avidity Partners Management
Dallas,
Texas
|
$0 |
